The conditional mutator phenotype in human tumor cells: correction
Meuth, M.; Richards, B.; Schneider, B.
Science 283(5402): 641
1999
ISSN/ISBN: 0036-8075 PMID: 9988656 Document Number: 499733
A correction to an article on conditional mutator phenotypes in hMSH2-deficient tumor cell lines, which appeared in the September 5, 1997, issue. The writers report that more recent experiments using a new serum batch could explain differences in mutant frequencies found in the original experiments.
Document emailed within 1 workday
Related Documents
Caligo, M.A.; Ghimenti, C.; Sensi, E.; Piras, A.; Rainaldi, G. 1999: Microsatellite instability is co-selectable with gene amplification in a mammalian mutator phenotype Anticancer Research 19(2a): 1271-1275Khmel'nitskiĭ, M.I.; Zlotnikov, K.M. 1979: Comparative study of mutator-gene prv and several other mutator-genes of Escherichia coli K-12 Genetika 15(5): 823-830
Adams, P.W.; Lee, H.S.; Waldman, W.J.; Sedmak, D.D.; Morgan, C.J.; Ward, J.S.; Orosz, C.G. 1992: Alloantigenicity of human endothelial cells. 1. Frequency and phenotype of human T helper lymphocytes that can react to allogeneic endothelial cells Journal of Immunology 148(12): 3753-3760
Colburn, N.H.; Smith, B.M.; Wendel, E.J.; Dowjat, W.K.; Shimada, T. 1988: Transfer by pro gene transfection of tumor promoter-sensitive phenotype to promotion-insensitive JB6 cells Cancer Research 48(5): 1195-1200
Tanigawa, N.; Mizuno, Y.; Hashimura, T.; Honda, K.; Satomura, K.; Hikasa, Y.; Niwa, O.; Sugahara, T.; Yoshida, O.; Kern, D.H. 1984: Comparison of drug sensitivity among tumor cells within a tumor, between primary tumor and metastases, and between different metastases in the human tumor colony-forming assay Cancer Research 44(6): 2309-2312
Vol'pe, E.A. 1991: The resistance of in vivo selected tumor cells of malignant phenotype to the cytolytic action of activated peritoneal macrophages in vitro Biulleten' Eksperimental'noi Biologii i Meditsiny 111(2): 177-179
Merluzzi, V.J.; Faanes, R.B.; Czajkowski, M.; Last-Barney, K.; Harrison, P.C.; Kahn, J.; Rothlein, R. 1987: Membrane-associated interleukin 1 activity on human U937 tumor cells: stimulation of PGE2 production by human chondrosarcoma cells Journal of Immunology 139(1): 166-168
Philchenkov, A.A.; Shishko, E.D.; Zavelevich, M.P.; Kuiava, L.M.; Miura, K.; Blokhin, D.Y.; Shton, I.O.; Gamaleia, N.F. 2014: Photodynamic responsiveness of human leukemia Jurkat/A4 cells with multidrug resistant phenotype Experimental Oncology 36(4): 241-245
Takada, H.; Hiromatsu, K.; Matsuzaki, G.; Muramori, K.; Nomoto, K. 1993: Peritoneal gamma delta T cells induced by Escherichia coli infection in mice. Correlation between Thy-1 phenotype and host minor lymphocyte-stimulating phenotype Journal of Immunology 151(4): 2062-2069
Chekhun, S.V.; Lukyanova, N.Y.; Shvets, Y.V.; Burlaka, A.P.; Buchinska, L.G. 2014: Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells Experimental Oncology 36(3): 179-183
Cardi, G.; Mastrangelo, M.J.; Berd, D. 1989: Depletion of T-cells with the CD4+CD45R+ phenotype in lymphocytes that infiltrate subcutaneous metastases of human melanoma Cancer Research 49(23): 6562-6565
Lautier, D.; Lahmy, S.; Canitrot, Y.; Vigo, J.; Viallet, P.; Salmon, J.M. 1993: Detection of human leukemia cells with multidrug-resistance phenotype using multilabeling with fluorescent dyes Anticancer Research 13(5a): 1557-1563
Bracke, M.E.; Charlier, C.; Bruyneel, E.A.; Labit, C.; Mareel, M.M.; Castronovo, V. 1994: Tamoxifen restores the E-cadherin function in human breast cancer MCF-7/6 cells and suppresses their invasive phenotype Cancer Research 54(17): 4607-4609
Hatton, D.H.; Mitchell, D.L.; Strickland, P.T.; Johnson, R.T. 1995: Enhanced photoproduct repair: its role in the DNA damage-resistance phenotype of human malignant melanoma cells Cancer Research 55(1): 181-189
Lu, Y.; Ge, X.; Fu, S. 1997: Suppression of metastatic phenotype of cloned mouse lung adenocarcinoma cells by transfer of human genomic DNA Zhonghua Yi Xue Za Zhi 77(11): 829-833
Koldovsky, P.; Weinstein, J. 1973: Expression of non-tumor-specific antigen in human tumor cells National Cancer Institute Monograph 37: 33-35
Golden-Mason, L.; Douek, D.C.; Koup, R.A.; Kelly, J.; Hegarty, J.E.; O'Farrelly, C. 2004: Adult human liver contains CD8pos T cells with naive phenotype, but is not a site for conventional alpha beta T cell development Journal of Immunology 172(10): 5980-5985
Herman, C.J.; Pelgrim, O.; Kirkels, W.J.; Debruyne, F.M.; Vooijs, G.P. 1983: 'Viable' tumor cells in posttherapy biopsy specimens. a potential application of human tumor clonogenic cell culture Archives of Pathology and Laboratory Medicine 107(2): 81-83
Totpal, K.; Agarwal, S.; Aggarwal, B.B. 1992: Phosphatase inhibitors modulate the growth-regulatory effects of human tumor necrosis factor on tumor and normal cells Cancer Research 52(9): 2557-2562
Pagliacci, M.C.; Fumi, G.; Migliorati, G.; Grignani, F.; Riccardi, C.; Nicoletti, I. 1993: Cytostatic and cytotoxic effects of tumor necrosis factor alpha on MCF-7 human breast tumor cells are differently inhibited by glucocorticoid hormones Lymphokine and Cytokine Research 12(6): 439-447